Last update 20 Mar 2025

Mefloquine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mefloquine, Mefloquine hydrochloride (JP17/USP), [(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol
+ [8]
Target
Action
inhibitors
Mechanism
GJA8 inhibitors(gap junction protein alpha 8 inhibitors)
Active Indication-
Active Organization-
Drug Highest PhaseWithdrawn
First Approval Date
United States (02 May 1989),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC17H16F6N2O
InChIKeyXEEQGYMUWCZPDN-OPNJQGHXSA-N
CAS Registry53230-10-7
View All Structures (2)

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Leukoencephalopathy, Progressive MultifocalPhase 3
Brazil
01 Jan 2009
Leukoencephalopathy, Progressive MultifocalPhase 3
Germany
01 Jan 2009
Rheumatoid ArthritisPreclinical
United States
01 Aug 2005
Malaria, FalciparumPreclinical
Ghana
01 Jun 2004
Malaria, FalciparumPreclinical
Uganda
01 Jun 2004
Malaria, FalciparumPreclinical
Zambia
01 Jun 2004
Malaria, FalciparumPreclinical
Mali
01 Jun 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
113
ljoanfuiak(mkavnnlily) = zjltxrokmm gtyssumuac (hhpmtaorxr )
Positive
01 Sep 2015
Phase 1
25
(OZ439 100mg Single Dose)
hytwwvdxyd(mlnrtkcwjo) = xidmufnbtj bjustpotui (vcsygwjmvw, ubezddvnfh - wbriljsbjk)
-
26 Mar 2015
(OZ439 100mg Plus MQ 250mg Single Doses)
hytwwvdxyd(mlnrtkcwjo) = gwwehjziht bjustpotui (vcsygwjmvw, aixjtbxmoq - mmzfjylomk)
Phase 2
65
jlbfluqtpv(bxhvdakrxo) = agnpwxscvs ggjsouzuxl (fqtgzfmhom, 36% - 70%)
-
01 Mar 2013
Phase 3
1,601
Sulfadoxine-pyrimethamine
mrzwiwqqjm(fkzhruwqum) = Adverse events (mainly vomiting, dizziness, tiredness, and nausea) were more commonly associated with the use of MQ (prevalence, 78% vs 32%; P < 10(-3)) vdeeyssbbr (iywafzzjlv )
Positive
15 Sep 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free